抗CD4和抗IL6单克隆抗体联合治疗1例严重脊柱关节病 - Suppr | 超能文献

Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy.

作者信息

Wendling D, Racadot E, Toussirot E, Wijdenes J

出版信息

Br J Rheumatol. 1996 Dec;35(12):1330. doi: 10.1093/rheumatology/35.12.1330.

DOI:10.1093/rheumatology/35.12.1330

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy.抗CD4和抗IL6单克隆抗体联合治疗1例严重脊柱关节病

Br J Rheumatol. 1996 Dec;35(12):1330. doi: 10.1093/rheumatology/35.12.1330.

2

Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.炎症性骨损伤的分子机制：新兴的治疗靶点

Trends Mol Med. 2008 Jun;14(6):245-53. doi: 10.1016/j.molmed.2008.04.001. Epub 2008 May 9.

3

Modulation of the CD4 molecule is a major event in the induction of transplantation tolerance with anti-CD4 monoclonal antibodies.CD4分子的调节是利用抗CD4单克隆抗体诱导移植耐受过程中的一个主要事件。

Transplant Proc. 1997 Feb-Mar;29(1-2):1159. doi: 10.1016/s0041-1345(96)00504-0.

4

The new era of biological treatments.生物治疗的新时代。

Isr Med Assoc J. 2014 Dec;16(12):793-8.

5

In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis.强直性脊柱炎患者在肿瘤坏死因子-α阻断治疗期间T细胞对回忆抗原反应性的体外观察

J Rheumatol. 2007 Nov;34(11):2264-70. Epub 2007 Oct 1.

6

Dominant infiltration by TH2 cells into grafts following treatment with anti-CD4 monoclonal antibody.用抗CD4单克隆抗体治疗后，TH2细胞向移植物的优势浸润。

Transplant Proc. 1997 Feb-Mar;29(1-2):1053. doi: 10.1016/s0041-1345(96)00373-9.

7

Anti-tumor necrosis factor therapies reduce serum macrophage inflammatory protein-1alpha in ankylosing spondylitis.抗肿瘤坏死因子疗法可降低强直性脊柱炎患者血清中的巨噬细胞炎性蛋白-1α水平。

J Rheumatol. 2010 May;37(5):1073-4. doi: 10.3899/jrheum.091469.

8

Interleukin-17 targeted therapies in axial spondyloarthritis.轴性脊柱关节炎的白细胞介素-17靶向治疗

Immunotherapy. 2015;7(11):1125-8. doi: 10.2217/imt.15.85. Epub 2015 Oct 29.

9

Interleukin 6 blockade in spondyloarthritis.脊柱关节炎中白细胞介素6的阻断

J Rheumatol. 2012 May;39(5):1097-8; author reply 1098. doi: 10.3899/jrheum.110955.

10

Ankylosing spondylitis refractory to tumor necrosis factor blockade responds to tocilizumab.对肿瘤坏死因子阻断治疗无效的强直性脊柱炎对托珠单抗有反应。

J Rheumatol. 2011 Jul;38(7):1527. doi: 10.3899/jrheum.110265.

引用本文的文献

1

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.IL-6 是否为治疗抗 TNF 治疗抵抗的脊柱关节炎患者的合适靶点？一项多中心回顾性观察研究。

Arthritis Res Ther. 2012 Mar 9;14(2):R53. doi: 10.1186/ar3766.

2

The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis.轻度全身热疗对强直性脊柱炎患者体内肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-6系统水平的影响。

Clin Rheumatol. 2009 Apr;28(4):397-402. doi: 10.1007/s10067-008-1059-x. Epub 2008 Dec 17.

3

Current guidelines for the drug treatment of ankylosing spondylitis.强直性脊柱炎药物治疗的现行指南。

Drugs. 1998 Aug;56(2):225-40. doi: 10.2165/00003495-199856020-00006.